DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER
Clinical Trials for Dextrose 5% And Ringer's In Plastic Container
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00113685 | Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury | Completed | National Heart, Lung, and Blood Institute (NHLBI) | N/A | The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness. |
| NCT00113685 | Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury | Completed | University of Washington | N/A | The purpose of this study is to evaluate the clinical outcome of patients following blunt traumatic injury with hypovolemic shock, who receive either lactated ringer's solution or hypertonic saline with dextran (HSD) resuscitation; also, to focus specifically on neurologic outcome in patients with brain injury and on the effect of HSD resuscitation on inflammatory cell responsiveness. |
| NCT00119184 | Spinal Analgesia Versus No Analgesia: Study for External Cephalic Version | Terminated | Hadassah Medical Organization | Phase 1 | The purpose of this study is to examine whether spinal anesthesia affects the chances of successful external cephalic version (ECV) of a breech presenting fetus. Two study groups will be included; one will receive spinal anesthesia, the other will not. The non-spinal group will be permitted to cross over if ECV procedure is painful. The main outcome is success of ECV. |
| NCT00181077 | Hypertonic Saline Use in Preeclampsia | Completed | Johns Hopkins University | Phase 1 | To compare hypertonic saline to Lactated Ringer's solution and assess whether one speeds up the process of getting rid of extra body water faster in women with preeclampsia. |
| NCT00273728 | BaSES Trial: Basel Starch Evaluation in Sepsis | Completed | Fresenius AG | Phase 4 | Background: In patients with severe sepsis and septic shock early aggressive volume replacement reduced mortality. Standard infusion therapy consists of crystalloid infusions. The role of modern, low molecular weight, starch preparations and their influence on the course of disease is not determined yet. Hypothesis: The purpose of this study is to determine wether initial infusion therapy with Hydroxyethylstarch and Ringer's lactate reduces in septic patients reduces Intensive Care Unit and hospital length of stay without impairment of renal function Design: Double-blind, randomized, controlled monocentric study Setting: Intensive Care Units of a University Hospital Patients: 240 consecutive patients with sepsis, severe sepsis and septic shock Intervention: Volume therapy with Ringer's lactate and saline or hydroxy-ethyl starch (MW 130, substitution 0.4) in the first five days of intensive care treatment. Parameter: - Intensive Care length of stay - Hospital length of stay - Mortality - Kidney function Statistics: Mann-Whitney test for non-parametric data like intensive care length of stay. Unpaired t-Test for kidney function parameters. Study withdrawal: Significant impairment of kidney function parameters in the hydroxy-ethyl starch group |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Dextrose 5% And Ringer's In Plastic Container
Clinical Trial Locations for Dextrose 5% And Ringer's In Plastic Container
Trials by Country
Trials by US State
Clinical Trial Progress for Dextrose 5% And Ringer's In Plastic Container
Clinical Trial Sponsors for Dextrose 5% And Ringer's In Plastic Container
Sponsor Name
